Schmoll, H., Stein, A., Van Cutsem, E., Price, T., Hofheinz, R., Nordlinger, B., . . . Haustermans, K. (2020). Pre- and postoperative capecitabine without or with oxaliplatin in locally advanced rectal cancer: PETACC 6 trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD. Journal of clinical oncology, 39(1), . https://doi.org/10.1200/JCO.20.01740
Chicago-Zitierstil (17. Ausg.)Schmoll, Hans-Joachim, et al. "Pre- and Postoperative Capecitabine Without or with Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD." Journal of Clinical Oncology 39, no. 1 (2020). https://doi.org/10.1200/JCO.20.01740.
MLA-Zitierstil (9. Ausg.)Schmoll, Hans-Joachim, et al. "Pre- and Postoperative Capecitabine Without or with Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD." Journal of Clinical Oncology, vol. 39, no. 1, 2020, https://doi.org/10.1200/JCO.20.01740.